9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 34
- Q2 2023, −5 vs. previous quarter
- 13F value
- $2.08M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding NMTR, Q2 2023
No superinvestor reported holding NMTR at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by 9 Meters Biopharma, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2023 (view filing) | Apr 21 | Same day | Sensenig BethanyChief Financial Officer | SSale | −9.10K | $1.21 | −$11.0K | −18.1%41.1K after | |
| Jul 8, 2022 (view filing)8:01 AM ET | Jul 6 | 2 days | Temperato JohnChief Executive Officer | PPurchase | +125.0K | $0.2277 | +$28.5K | +9.6%1.43M after | |
| May 24, 2022 (view filing)4:01 PM ET | May 23 | 1 day | Constantino Michael T.Director | PPurchase | +16.0K | $0.4755 | +$7.61K | +35.9%60.5K after | |
| May 19, 2022 (view filing)4:09 PM ET | May 18 | 1 day | Temperato JohnChief Executive Officer | PPurchase | +50.0K | $0.4457 | +$22.3K | +4.0%1.30M after | |
| May 19, 2022 (view filing)4:01 PM ET | May 18 | 1 day | Sirgo Mark ADirector | PPurchase | +106.4K | $0.47 | +$50.0K | +8.3%1.39M after | |
| Mar 21, 2022 (view filing) | Aug 20, 2020 | 578 days | Constantino Michael T.Director | PPurchase | +26.5K | $0.75 | +$19.9K | New position26.5K after | Amended |
| Mar 7, 2022 (view filing) | Mar 3 | 4 days | Sirgo Mark ADirector | PPurchase | +86.4K | $0.58 | +$50.1K | +7.2%1.28M after | |
| Mar 4, 2022 (view filing) | Mar 3 | 1 day | Temperato JohnChief Executive Officer | PPurchase | +100.0K | $0.56 | +$56.0K | +8.7%1.25M after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Sirgo Mark ADirector | PPurchase | +50.0K | $0.89 | +$44.5K | +4.2%1.24M after | |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Sirgo Mark ADirector | PPurchase | +20.0K | $1.06 | +$21.2K | +1.7%1.19M after |
Top 10 13F holders, Q2 2023
The largest institutional positions in 9 Meters Biopharma, Inc. at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 1,038,440 | $697.8K | 2.50% | −65,205−5.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 650,000 | $436.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 619,829 | $416.5K | 0.00% | −8,477−1.3% | Reduced |
| Laurion Capital Management LP | 218,710 | $147.0K | 0.01% | −9,200−4.0% | Reduced |
| BlackRock Inc. | 167,949 | $112.9K | 0.00% | −90−0.1% | Reduced |
| Geode Capital Management, LLC | 108,821 | $73.1K | 0.00% | −30.0% | Reduced |
| State Street Corp | 50,908 | $34.2K | 0.00% | 00.0% | Unchanged |
| ODonnell Financial Services, LLC | 43,410 | $29.2K | 0.02% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 37,905 | $25.0K | 0.00% | +20+0.1% | Added |
| CIBC Asset Management Inc | 32,722 | $22.0K | 0.00% | 00.0% | Unchanged |